Comparison between positivity impact of Estrogen receptors and Progesterone receptors in treatment of early Breast Cancer patients
LMJ-Lebanese Medical Journal. 2019; 67 (suppl.): 30
in English
| IMEMR
| ID: emr-206746
ABSTRACT
Background:
Estrogen [ER] and progesterone [PR] are important factors in prognosis and treatment of breast cancer patients. Many studies suggest that disease free survival [DFS] differs when one of these receptors is positive and the other is negative. We aim to study the impact of positivity of estrogen receptors comparing with progesterone receptors on DFS in early breast cancer
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
Lebanese Med. J.
Year:
2019
Similar
MEDLINE
...
LILACS
LIS